Daniel Mines MD MSCE

Executive Director, Epidemiology, Merck Research Laboratories

604 E Moreland AveWyndmoor, PA 19038
Phone+1 215-233-1845

Dr. Mines is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mines' full profile Already have an account?

Education & Training

Penn MedicinePost-Doctoral Fellowship, 1997 - 1999
University of Pennsylvania Health SystemResidency, Internal Medicine, 1985 - 1988
Perelman School of Medicine at the University of PennsylvaniaClass of 1985

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

PA State Medical License 1986 - 2026
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

3 citations
Cardiovascular events and all-cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long-acting beta2-agonists.
Cristina Rebordosa, Dóra Körmendiné Farkas, Jukka Montonen, Kristina Laugesen, Florian Voss
Pharmacoepidemiology and Drug Safety. 2022-08-01
31 citations
Development of a risk prediction model to individualize risk factors for surgical site infection after mastectomy
Margaret A. Olsen, Katelin B. Nickel, Julie A. Margenthaler, Ida K. Fox, Kelly E. Ball
Annals of Surgical Oncology. 2016-01-28
19 citations
Topiramate use during pregnancy and major congenital malformations in multiple populations.
Patricia Tennis, K. Arnold Chan, Suellen M. Curkendall, De-Kun Li, Daniel Mines
Birth Defects Research. Part A, Clinical and Molecular Teratology. 2015-04-01